🔎 Trials Near Me

Nyumbani › Limfoma ya Selu Kubwa za B Diffuse › North Carolina › Durham

Majaribio ya kliniki ya Limfoma ya Selu Kubwa za B Diffuse katika Durham, NC

Masomo 14 ya Limfoma ya Selu Kubwa za B Diffuse yanatafuta washiriki katika vituo vya Durham na maeneo yake (ndani ya takriban maili 30). Fungua somo kuona nani anaweza kujiunga na jinsi ya kuwasiliana na timu ya utafiti.

Maandishi rasmi ya utafiti (Kiingereza)

Unavutia washiriki kwa utafiti hapa? Weka juu ya ukurasa huu — $99 kwa siku 30 →

Consolidation of First-Line MRD+ Remission With Cema-cel in Patients With LBCL

InaajiriHatua 2
  • Duke Blood Cancer Center, Durham
Umri 18 na zaidi · Jinsia zote · Imesasishwa 2 Okt 2026 · NCT06500273

A Clinical Study of Zilovertamab Vedotin (MK-2140) Plus Rituximab Plus Cyclophosphamide, Doxorubicin, and Prednisone (R-CHP) Versus Polatuzumab Vedotin Plus R-CHP in People With Diffuse Large B-cell Lymphoma (DLBCL) (MK-2140-011/waveLINE-011)

InaajiriHatua 2
  • University of North Carolina Medical Center ( Site 0136), Chapel Hill · Mi 10 mbali
Umri 18 na zaidi · Jinsia zote · Imesasishwa 25 Sep 2026 · NCT06890884

Gene Therapy for CD19-Positive Hematologic Malignancies (SENTRY-CD19)

InaajiriHatua 1/2
  • University of North Carolina at Chapel Hill/ University of North Carolina Medical Center, Chapel Hill · Mi 10 mbali
Umri 13 hadi 90 · Jinsia zote · Imesasishwa 6 Ago 2026 · NCT06533579

Lentiviral Gene Therapy (Zamtocabtagene Autoleucel) LTFU

InaajiriUtafiti wa uchunguzi
  • Duke University Medical Center - Division of Hematologic Malignancies, Durham
Umri 18 na zaidi · Jinsia zote · Imesasishwa 5 Ago 2026 · NCT06116110

A Study to Investigate Ronde-cel Versus Investigator's Choice CD19 CAR T-Cell Therapy

InaajiriHatua 3
  • Duke Cancer Institute, Durham
Umri 18 na zaidi · Jinsia zote · Imesasishwa 4 Ago 2026 · NCT07188558

DALY II USA/ MB-CART2019.1 for DLBCL

InaajiriHatua 2
  • Duke University Medical Center - Division of Hematologic Malignancies, Durham
Umri 18 na zaidi · Jinsia zote · Imesasishwa 13 Jul 2026 · NCT04792489

A Study of NX-5948 in Adults With Relapsed/Refractory B-cell Malignancies

InaajiriHatua 1
  • Duke University Medical Center, Durham
Umri 18 na zaidi · Jinsia zote · Imesasishwa 2 Jul 2026 · NCT05131022

Registry of Older Patients With Cancer

InaajiriUtafiti wa uchunguzi
  • Lineberger Comprehensive Cancer Center at University of North Carolina - Chapel Hill, Chapel Hill · Mi 10 mbali
Umri 65 na zaidi · Jinsia zote · Imesasishwa 29 Jun 2026 · NCT01137825

Study of Oral Administration of LP-168 in Patients With Relapsed or Refractory B-cell Malignancies.

InaajiriHatua 1
  • Duke Univerisity, Durham
Umri 18 na zaidi · Jinsia zote · Imesasishwa 13 Feb 2026 · NCT04775745

Tissue, Blood, and Body Fluid Sample Collection From Patients With Hematologic Cancer

InaajiriUtafiti wa uchunguzi
  • Lineberger Comprehensive Cancer Center at University of North Carolina - Chapel Hill, Chapel Hill · Mi 10 mbali
Umri 18 hadi 120 · Jinsia zote · Imesasishwa 27 Okt 2025 · NCT01137643

A Study of AC676 for the Treatment of Relapsed/Refractory B-Cell Malignancies

InaajiriHatua 1
  • University of North Carolina, Chapel Hill · Mi 10 mbali
Umri 18 na zaidi · Jinsia zote · Imesasishwa 2 Okt 2025 · NCT05780034

A Study of NX-1607 in Adults With Advanced Malignancies

InaajiriHatua 1
  • University of North Carolina, Chapel Hill · Mi 10 mbali
Umri 18 na zaidi · Jinsia zote · Imesasishwa 9 Sep 2025 · NCT05107674

Epcoritamab Compared to Observation for Treating B-cell Lymphoma Patients Not in Complete Remission After CD19-directed CAR-T Therapy

InaajiriHatua 2
  • UNC Lineberger Comprehensive Cancer Center, Chapel Hill · Mi 10 mbali
Umri 18 na zaidi · Jinsia zote · Imesasishwa 26 Sep 2024 · NCT06238648

Majaribio ya Limfoma ya Selu Kubwa za B Diffuse katika miji mingine

Masomo mengine katika Durham

Kutoka ClinicalTrials.gov, data iliyopatikana 5 Okt 2026. Kila utafiti una masharti yake ya kufaa; timu ya utafiti huamua nani anaweza kujiunga.